Koninklijke Philips/€PHIA

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About Koninklijke Philips

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Ticker

€PHIA
Sector

Primary listing

AEX

Employees

67,263

PHIA Metrics

BasicAdvanced
€23B
137.28
€0.17
0.84
€0.85
3.55%

What the Analysts think about PHIA

Analyst ratings (Buy, Hold, Sell) for Koninklijke Philips stock.

Bulls say / Bears say

Philips achieved a 12.4% adjusted EBITA margin in Q2 2025—130 basis points above last year—driven by productivity improvements and a favorable product mix led by innovation, offsetting tariff and currency headwinds. (Reuters)
Comparable order intake rose 6% in Q2 2025, powered by new AI-driven diagnostic systems, strengthening the future revenue pipeline across all segments. (Reuters)
The company secured a long-term national agreement with Indonesia’s Ministry of Health to roll out its Azurion image-guided therapy platform across all 38 provinces, broadening access to advanced cardiac, stroke and cancer care for more than 280 million people. (Reuters)
Philips forecasts a mid- to high-single-digit decline in China sales for 2025—China now represents about 10% of revenue—highlighting ongoing exposure to anti-corruption initiatives and trade tensions that could further limit revenue growth. (Reuters)
In May 2025 Philips lowered its 2025 adjusted EBITA margin outlook to 10.8%–11.3%, down from 11.8%–12.3%, citing a €250–300 million tariff impact and sustained profit pressure from geopolitical challenges. (Reuters)
Despite mitigation actions, Philips stated the tariff situation remains fluid, with the risk of further cost increases beyond the €150–200 million already estimated, adding continued uncertainty to margins. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 3 Oct 2025.

PHIA Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

PHIA Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €PHIA

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs